Praveen Sundar

Amrita Institute of Medical Sciences and Research Centre

Papers

Total Citations

H-Index

About

Praveen Sundar is a urologic oncologist whose research focuses on improving outcomes for high-risk prostate cancer, particularly within the Indian population. His most cited work, a 2018 study on pathological outcomes and biochemical recurrence-free survival after radical prostatectomy, directly addresses the pressing need for region-specific data on this aggressive disease. By analyzing patients classified under the D’Amico criteria, Sundar’s research provides critical insights into how the number and type of risk factors—such as tumor stage—influence long-term cancer control. This work, with 9 citations, has helped refine surgical decision-making for a demographic often underrepresented in global trials. Additionally, his case report on Castleman’s Disease, a rare lymphoproliferative disorder, showcases his diagnostic acumen in identifying unusual presentations, such as a suprarenal mass. Through these contributions, Sundar bridges the gap between established oncologic principles and the unique clinical realities of his patient population, advancing both surgical practice and personalized care in urologic oncology.